Skip to content

Using the Delphi method to formulate the criteria of COPD development ”fast” and”slow” and study the differences of its TCM constitution' the banlance of T-cells and ADAM33 Gene polymorphism

Using the Delphi method to formulate the criteria of COPD development ”fast” and”slow” and study the differences of its TCM constitution' the banlance of T-cells and ADAM33 Gene polymorphism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCH-13003487
Enrollment
Unknown
Registered
2013-03-25
Start date
2013-01-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary diseases

Interventions

group of progress 'fast':NA
group of progress"slow":NA
group of health:NA

Sponsors

Traditional Chinese Medicine Hospital of Xinjiang uygur autonomous region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Aged 30~85, in line with the criteria of COPD development "fast”and”slow"; 2) Patients not taking hormone and other immunosuppressor,sametime not received desensitization treatment within a past month; 3) outpatient or inpatient with oral or written informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with severe respiratory failure, pulmonary encephalopathy or artificial mechanical ventilation therapy (noninvasive or invasive) cannot cooperate syndrome information acquisition; 2. patients had other respiratory system diseasesa that greater influence on TCM syndrome,shth as bronchiectasis; 3. Merge other organs serious primary diseases(e.g., heart, brain, liver, kidney, etc.); 4. Psychiatric patients; 5. With acute infectious disease happend or aggravated within a past month; 6. Outpatients or inpatients don't agree to participate in this research.

Design outcomes

Primary

MeasureTime frame
Th17/Treg;ROR?t;ADAM33 genes SNPs (T2, V4, T1);IL-17;TGF-ß;IL-6;

Countries

China

Contacts

Public Contactfengsen-Li
fengsen602@163.com+86 13999980996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026